This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of fingolimod
MSMED_FINGOLIMOD
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
349 |
4. Check minimum number of events
Min. number of events
3
|
349 |
5. Include endpointsNone |
349 |
6. Filter based on genotype QC (FinnGen only) |
349 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Use of fingolimod
based on the number of shared cases.
Similar with more cases:
- MS-disease / Multiple Sclerosis
- Demyelinating diseases of the central nervous system
- L04AA Selective immunosuppressants
- Other degenerative diseases of the nervous system
- ILD medications: immunosuppressive drugs
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 349 | 285 | 64 |
| Unadjusted period prevalence (%) | 0.08 | 0.10 | 0.03 |
| Median age at first event (years) | 38.21 | 37.82 | 39.94 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 304
- Matched controls
- 3039
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L04AA27
ATC
fingolimod; oral
+∞
323.0
304
*
164
Kela drug reimbursment
Fingolimod
+∞
323.0
304
*
353
Kela drug reimbursment
Cladribine and fingolimod
+∞
323.0
267
*
G35
ICD-10 Finland
Multiple sclerosis
+∞
323.0
304
25
109
Kela drug reimbursment
Multiple sclerosis
11336.6
323.0
300
18
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
1012.2
306.9
254
15
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
873.4
302.7
253
17
L03AB07
ATC
interferon beta-1a; parenteral
562.6
193.3
173
7
L03AX13
ATC
glatiramer acetate; parenteral
1162.9
188.5
165
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
52.3
169.6
217
138
N86
ICPC
Multiple sclerosis
499.3
130.3
121
*
H46
ICD-10 Finland
Optic neuritis
148.0
127.6
129
15
L03AB08
ATC
interferon beta-1b; parenteral
710.8
105.5
98
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
17.1
97.2
181
240
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
99.1
85.1
91
13
N04BB01
ATC
amantadine; oral
96.3
73.4
79
11
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
56.6
68.4
80
19
M03BX01
ATC
baclofen; systemic
61.3
61.6
71
15
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
68.2
61.0
69
13
ZX120
NOMESCO Finland
Intravenous
15.7
51.8
89
78
2AB04
NOMESCO Finland
NA
290.8
49.6
49
*
L04AA31
ATC
teriflunomide; oral
113.6
45.3
48
5
XCW99
NOMESCO Finland
Other investigative procedure of eye
12.5
45.1
86
93
XKD00
NOMESCO Finland
Uroflowmetry
16.5
44.6
74
58
TAB00
NOMESCO Finland
Lumbar puncture
12.8
43.2
81
84
XCK00
NOMESCO Finland
Perimetry
17.5
42.8
69
50
G04BD12
ATC
mirabegron; oral
15.6
42.5
72
59
L04AX07
ATC
dimethyl fumarate; oral
99.9
40.0
43
5
H02AB04
ATC
methylprednisolone; systemic
7.3
39.2
108
214
4AA23
NOMESCO Finland
NA
209.8
36.6
37
*
N07XX09
ATC
[U] dimethyl fumarate; oral
209.8
36.6
37
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
26.9
34.8
48
21
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
8.8
33.8
78
115
N06BA07
ATC
modafinil; oral
101.8
33.5
36
*
G04BD09
ATC
trospium; oral
34.5
32.6
42
14
XA800
NOMESCO Finland
Neuropsychological investigation
13.3
32.2
58
53
XKC03
NOMESCO Finland
Water cystometry
21.9
28.8
42
22
G04BD08
ATC
solifenacin; oral
15.7
28.4
47
35
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
7.9
27.6
67
105
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
12.8
27.6
50
46
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
102.5
26.1
28
*
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
283.4
26.1
26
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
8.5
25.7
59
84
UKC02
NOMESCO Finland
Cystoscopy
7.6
25.5
63
101
N03AX12
ATC
gabapentin; oral
5.4
25.1
85
205
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
271.4
25.1
25
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
8.5
24.5
56
79
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
18.1
23.9
37
23
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
10.3
23.3
47
53
N05CF01
ATC
zopiclone; oral
3.6
21.2
121
470
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
8.1
20.3
47
67
N03AX16
ATC
pregabalin; oral
3.8
20.2
101
349
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
12.6
19.6
35
31
R20.2
ICD-10 Finland
Paraesthesia of skin
5.8
19.3
58
119
Z3226
NOMESCO Finland
Physiotherapist
4.0
18.6
84
264
H53.2
ICD-10 Finland
Diplopia
13.1
18.3
32
27
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
6.7
17.5
46
79
TKC22
NOMESCO Finland
Catheterisation instruction
27.5
17.2
23
9
R35
ICD-10 Finland
Polyuria
8.4
17.0
38
51
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
+∞
16.8
16
*
A02BC02
ATC
pantoprazole; systemic
2.9
16.8
211
1336
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
24.7
16.7
23
10
R1250
NOMESCO Finland
Evaluation of functional capability
15.5
16.7
27
19
C10AC01
ATC
colestyramine; oral
12.2
16.1
29
26
G04BD07
ATC
tolterodine; oral
12.7
15.9
28
24
G36.0
ICD-10 Finland
Neuromyelitis optica [Devic]
+∞
15.8
15
*
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
40.4
15.6
19
5
XCK10
NOMESCO Finland
Photography of fundus of eye
6.2
15.4
42
76
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.1
14.5
98
408
N29
ICPC
Neurological sympt/complt other
18.7
14.0
21
12
N03AE01
ATC
clonazepam; systemic
6.4
13.7
36
62
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
13.6
113
536
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
11.2
13.5
25
24
L28
ICPC
Limited function/disability (L)
4.7
13.5
47
113
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
42.1
13.3
16
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
4.0
13.3
56
162
SPAT1229
SPAT
Assessment of need for aid
7.5
13.3
31
45
RF120
NOMESCO Finland
NA
20.2
13.1
19
10
Z2445
NOMESCO Finland
Psychologist
5.6
12.8
38
76
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
+∞
12.6
12
*
L04AA40
ATC
cladribine; oral
+∞
12.6
12
*
Z3229
NOMESCO Finland
Other healthcare associate professional
5.1
12.4
40
88
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
39.3
12.3
15
*
XKD03
NOMESCO Finland
Urethral pressure profilometry
13.2
12.3
21
17
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
10.7
12.2
23
23
RF420
NOMESCO Finland
NA
19.0
12.2
18
10
RF410
NOMESCO Finland
NA
22.4
12.1
17
8
Z3231
NOMESCO Finland
Registered nurse
2.7
12.1
101
474
G04BD04
ATC
oxybutynin; oral, transdermal
9.2
11.8
24
28
L01BB04
ATC
cladribine; systemic
+∞
11.5
11
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
12.5
11.5
20
17
J05AB01
ATC
aciclovir; systemic
2.7
11.1
91
420
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
7.7
11.0
25
35
L03AB13
ATC
peginterferon beta-1a; parenteral
45.1
11.0
13
*
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
29.2
10.8
14
5
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
22.4
10.8
15
7
J01EA01
ATC
trimethoprim; systemic
2.5
10.6
103
521
R4110
NOMESCO Finland
Physiotherapy
2.6
10.3
86
398
R4120
NOMESCO Finland
Occupational therapy
4.9
10.1
33
74
N30.0
ICD-10 Finland
Acute cystitis
3.2
10.0
56
201
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
20.9
9.9
14
7
G04CA01
ATC
alfuzosin; oral
8.3
9.8
21
27
N04BD01
ATC
selegiline; oral
56.9
9.7
11
*
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
6.4
9.4
24
40
J05AB11
ATC
valaciclovir; oral
3.1
9.4
56
209
N39.4
ICD-10 Finland
Other specified urinary incontinence
4.7
9.4
31
71
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.5
9.3
27
53
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.5
9.2
32
77
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.9
8.7
28
62
R4150
NOMESCO Finland
Neuropsychological rehabilitation
12.1
8.7
15
13
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
28.4
8.5
11
*
G04BD11
ATC
fesoterodine; oral
11.2
8.4
15
14
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
7.9
8.3
18
24
A06AD11
ATC
lactulose; oral
3.9
8.1
33
93
J01AA02
ATC
doxycycline; systemic
2.2
7.9
239
1906
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
46.2
7.8
9
*
G50.0
ICD-10 Finland
Trigeminal neuralgia
12.3
7.6
13
11
SPAT1325
SPAT
Vaccination
2.2
7.6
87
467
J01CA08
ATC
pivmecillinam; oral
2.0
7.5
155
1052
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
82.0
7.4
8
*
U13
ICPC
Bladder symptom/complaint other
8.7
7.4
15
18
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
+∞
7.3
7
*
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
30.8
7.2
9
*
G51.0
ICD-10 Finland
Bell palsy
6.6
7.0
17
27
H02AB06
ATC
prednisolone; systemic
1.9
7.0
143
960
RS340
NOMESCO Finland
NA
41.0
6.8
8
*
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
14.7
6.4
10
7
Z2446
NOMESCO Finland
Social worker
3.5
6.4
29
90
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
27.3
6.3
8
*
SPAT1231
SPAT
Assessment of adjustments needed in living environment
27.3
6.3
8
*
H53.1
ICD-10 Finland
Subjective visual disturbances
3.5
6.2
27
82
Z50.1
ICD-10 Finland
Other physical therapy
4.3
6.1
21
51
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
12.9
6.1
10
8
N06AX16
ATC
venlafaxine; oral
2.2
6.1
66
342
M03BX02
ATC
tizanidine; oral
1.9
6.1
210
1653
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014148) Varicella zoster virus Ab [Titer] in Serum
137
59
37.58
200.56
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
135
59
36.69
196.39
1.2
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
281
864
12.56
103.20
16.7
5.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
90
8
150.92
87.79
2.9
2.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
126
196
9.50
83.86
4.6
2.0
g/l
9.1
10.2
3.77
120
182
(3011412) CD3 cells [#/volume] in Blood
60
28
25.67
82.43
3.1
2.4
e9/l
0.9
1.4
1.28
36
13
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
54
19
33.44
81.96
2.2
2.7
%
15.4
9.4
1.83
26
11
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
52
17
35.77
80.70
2.1
2.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
337
1619
32.45
70.31
20.4
8.3
e9/l
3.4
3.9
11.04
332
1430
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
220
739
6.35
65.28
7.3
2.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
186
555
6.03
62.65
5.7
2.3
e6/l
0.1
0.2
1.53
161
398
(3002582) Erythrocytes [#/volume] in Urine
197
624
5.95
61.78
6.3
2.4
e6/l
8.6
67.5
2.92
174
457
(36304419) Bacteria [Presence] in Urine
186
578
5.75
59.13
5.6
2.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
62
59
12.56
58.49
5.9
3.7
e9/l
3.4
4.0
1.65
62
59
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
62
59
12.56
58.49
6.0
3.9
%
67.5
56.4
9.51
62
59
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
52
41
14.73
54.95
1.2
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
272
1222
6.56
54.30
6.8
5.2
umol/l
9.7
9.5
0.19
264
1155
(3000060) B lymphocytes [#/volume] in Blood
34
11
34.14
52.38
2.1
1.9
e6/l
35.6
290.0
—
9
6
(3021589) Normoblasts [#/volume] in Blood
265
1220
5.87
49.66
18.3
7.2
e9/l
0.0
0.0
0.33
258
1000
(3026782) Osmolality of Urine
145
415
5.27
49.39
4.2
2.0
mosm/kgh2o
561.0
573.4
0.22
139
352
(3017181) Myelocytes/100 leukocytes in Blood
93
184
6.53
47.59
5.8
3.8
%
0.5
0.7
0.22
14
43
(3002179) Metamyelocytes/100 leukocytes in Blood
88
173
6.46
45.18
6.0
3.8
%
0.0
0.6
—
10
29
(3018095) Leukocytes [#/volume] in Urine
204
814
4.63
44.49
7.5
2.9
e6/l
19.8
108.6
0.98
178
503
(3021879) Hepatitis B virus core Ab [Presence] in Serum
116
298
5.33
44.38
1.5
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
87
175
6.29
43.53
6.2
3.9
%
0.0
0.1
1.08
11
38
(3025159) Blasts/100 leukocytes in Blood
85
168
6.37
43.29
6.2
3.9
%
0.0
0.2
—
10
32
(3010503) CD19 cells [#/volume] in Blood
33
18
20.14
41.77
3.6
2.2
e9/l
0.1
0.2
0.81
33
18
(3026008) Bacteria identified in Urine by Culture
169
632
4.25
39.17
4.1
2.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
31
17
19.92
39.09
1.3
1.1
miu/ml
1657.8
1558.2
0.15
31
17
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
110
312
4.69
36.61
4.8
2.1
e6/l
0.9
0.8
0.11
63
160
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
39
7
62.45
34.01
1.2
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
140
504
3.97
33.31
1.6
1.6
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
294
1762
5.24
32.44
10.8
3.5
e6/l
45.3
966.3
—
6
14
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
101
303
4.28
30.73
5.0
2.1
e6/l
6.3
4.1
0.39
53
151
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
221
1136
3.58
29.42
2.5
2.3
nmol/l
97.9
72.7
21.66
212
1083
(40758558) Short blood count panel - Blood
159
673
3.50
28.84
11.9
6.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
173
781
3.41
28.11
15.4
3.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
45
72
7.03
27.71
1.5
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
244
1386
3.53
26.59
7.8
2.8
estimate
0.0
0.0
0.00
74
257
(3021601) Nitrite [Presence] in Urine by Test strip
241
1365
3.47
26.25
9.7
3.9
estimate
0.0
0.0
0.50
73
266
(3035350) Ketones [Presence] in Urine by Test strip
241
1371
3.45
25.93
7.9
2.8
estimate
0.0
0.0
0.00
74
259
(3015736) pH of Urine
206
1088
3.18
24.77
5.9
2.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
24
21
12.20
23.36
1.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
56
130
4.94
23.21
1.5
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
287
1921
3.78
21.70
9.9
3.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
27
9
32.36
20.88
1.9
2.8
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
27
9
32.36
20.88
1.9
2.9
%
8.7
7.8
—
27
9
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
23
25
9.78
19.30
1.1
1.2
mg/l
54.8
31.3
1.41
16
20
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
25
31
8.61
19.00
4.5
1.9
e6/l
639.4
846.8
0.64
13
13
(4027681)
21
21
10.58
18.66
1.3
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
166
887
2.66
17.79
1.8
1.7
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
21
5
44.58
17.48
1.1
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
82
307
3.18
17.04
2.7
2.1
u/l
72.7
2764.5
2.84
20
128
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
20
5
42.31
16.51
1.6
4.0
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
19
20
9.99
16.25
3.0
3.0
%
50.3
44.3
—
11
5
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
180
1079
2.38
14.13
9.0
2.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
65
237
3.14
13.95
11.4
2.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
149
829
2.39
13.79
7.8
2.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
117
586
2.50
13.64
6.0
2.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
21
33
6.71
12.97
1.0
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
30
69
4.66
12.42
1.4
1.7
e6/l
0.9
129.8
0.96
24
56
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
30
69
4.66
12.42
1.2
1.7
e6/l
12.6
4.6
1.49
23
53
(3044290) Cell count panel - Cerebral spinal fluid
28
61
4.90
12.35
1.1
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
127
688
2.33
12.20
11.0
3.0
estimate
0.0
0.0
1.08
72
264
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
20
34
6.18
11.46
1.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
13
13
10.35
11.40
6.6
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
26
57
4.85
11.38
1.6
2.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
19
32
6.22
10.97
1.0
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
19
35
5.68
10.04
1.4
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
58
240
2.70
9.75
3.2
1.7
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
13
8
16.81
8.61
1.1
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
12
7
17.69
8.13
1.1
1.0
mg/g
4.5
6.4
—
12
7
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
225
2723
0.51
7.80
2.8
3.0
mmol/l
1.2
1.2
0.03
214
2607
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
238
2826
0.50
7.67
2.9
3.3
mmol/l
1.5
1.5
0.75
225
2714
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
243
2849
0.52
7.01
3.0
3.4
mmol/l
3.1
2.9
1.17
226
2727
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
241
2832
0.52
6.98
2.9
3.3
mmol/l
4.9
4.8
1.35
229
2724
(3044889) 12 lead EKG panel
221
1690
1.84
6.82
3.0
2.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
271
2224
1.98
6.56
5.9
2.8
u/l
55.0
35.1
5.29
266
2151
(3016018) Differential panel - Cerebral spinal fluid
13
25
5.36
6.54
1.2
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
156
1104
1.75
6.01
2.0
2.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
243
1955
1.80
5.89
6.1
6.3
u/l
74.4
71.8
0.53
234
1840
(3023511) Choriogonadotropin [Units/volume] in Urine
41
186
2.36
5.64
1.9
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
328
2951
2.85
5.54
13.4
9.3
mg/l
14.7
18.0
1.16
246
2221
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
47
229
2.22
5.49
1.3
1.2
—
19.7
—
0
9
(3007164) IgA [Mass/volume] in Serum or Plasma
105
685
1.76
5.25
2.8
1.4
g/l
1.7
2.1
5.65
86
455
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
470
0.35
4.88
1.8
2.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
25
4.51
4.59
1.2
1.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
310
2767
2.08
4.56
9.7
8.5
mmol/l
3.9
3.9
0.20
301
2679
(3032080) INR in Blood by Coagulation assay
101
677
1.69
4.49
3.0
4.8
inr
1.1
1.1
0.12
31
244
(3019550) Sodium [Moles/volume] in Serum or Plasma
308
2756
2.00
4.29
9.6
8.5
mmol/l
139.8
139.5
1.86
300
2681
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
38
189
2.13
4.22
1.2
1.3
miu/ml
174.4
278.8
1.21
14
96
(3013826) Glucose [Moles/volume] in Serum or Plasma
175
1369
1.56
4.03
3.2
3.6
mmol/l
6.0
6.2
1.54
166
1224
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
233
2658
0.63
3.87
2.8
3.2
mmol/l
5.5
5.6
0.45
215
2510
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
5
12.17
3.77
3.0
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
51
295
1.85
3.72
1.4
1.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
121
885
1.56
3.68
4.5
4.3
g/l
38.6
37.6
1.67
108
830
(3051651) Icteric interference index of Serum or Plasma
8
13
6.27
3.52
1.1
3.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
18
5.10
3.39
2.2
4.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
296
2674
1.70
3.20
11.9
7.3
ml/min/173m2
100.5
95.6
5.23
270
2144
(40761535) Cells panel - Urine sediment
30
157
2.00
2.95
11.2
3.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
17
4.79
2.93
1.1
3.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
9
6.76
2.88
1.2
2.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
48
739
0.59
2.87
1.4
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
83
592
1.53
2.74
8.8
2.9
kg/l
1.0
1.0
—
6
72
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
26
463
0.53
2.60
1.2
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
100
1288
0.69
2.57
1.9
2.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
15
312
0.46
2.37
1.2
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
75
1006
0.68
2.35
1.5
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
18
347
0.49
2.31
2.0
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
13
4.68
2.28
1.2
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
32
188
1.77
2.26
1.3
1.7
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
265
0.43
2.23
1.1
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
265
0.43
2.23
1.1
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
26
440
0.56
2.19
1.2
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
288
0.46
2.16
1.1
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
191
1.74
2.15
1.3
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
215
2400
0.73
2.13
3.5
3.9
mmol/mol
35.8
37.4
2.65
200
2307
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
331
0.52
2.01
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
13
266
0.47
1.99
1.1
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
13
266
0.47
1.99
1.1
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
21
3.38
1.97
1.0
2.6
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
10
40
2.54
1.85
2.0
1.8
kpa
5.1
5.0
—
10
40
(3027315) Oxygen [Partial pressure] in Blood
10
40
2.54
1.85
2.0
1.8
kpa
8.6
9.6
—
10
40
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
17
3.57
1.84
1.0
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
39
569
0.65
1.82
1.4
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
77
592
1.39
1.69
4.8
3.5
ph
7.4
7.4
0.09
16
104
(3008898) HLA-B27 [Presence]
10
210
0.46
1.66
1.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
39
556
0.66
1.63
1.2
1.2
u/ml
2.4
6.1
0.89
13
238
(3023368) Bacteria identified in Blood by Culture
61
456
1.41
1.58
3.6
3.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
15
3.37
1.53
1.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
180
0.49
1.44
1.6
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
44
598
0.70
1.43
1.5
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
262
2787
0.76
1.38
28.0
11.7
g/l
333.5
333.0
0.43
262
2771
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
119
1005
1.28
1.36
5.1
5.5
mmol/l
1.2
1.2
0.10
96
856
(36660697) Celiac disease serology panel - Serum
17
281
0.58
1.35
1.1
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
147
0.47
1.35
1.6
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
219
0.53
1.35
1.1
1.4
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
38
0.00
1.35
0.0
1.3
—
—
—
0
0
(3010421) pH of Blood
10
47
2.16
1.35
2.9
1.7
ph
7.4
7.4
—
10
40
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
113
1.72
1.34
3.5
2.1
iu/l
12.4
5.5
—
9
47
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
49
644
0.72
1.31
1.3
1.6
mmol/l
1.2
1.5
3.09
39
581
(3009542) Hematocrit [Volume Fraction] of Blood
282
2959
0.76
1.22
20.7
10.1
%
39.8
40.4
0.57
226
2567
(3013512) EKG study
63
496
1.33
1.20
3.0
2.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
20
2.52
1.15
1.0
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
36
0.00
1.14
0.0
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
113
1305
0.80
1.14
3.8
3.8
—
—
—
0
0
(4062490)
7
30
2.36
1.13
1.0
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
13
218
0.58
1.12
1.1
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
63
779
0.77
1.12
1.9
1.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
48
614
0.75
1.08
8.0
3.0
mmol/l
8.6
8.3
0.18
39
547
(3000764) Benzodiazepines [Presence] in Urine
16
251
0.62
1.06
7.8
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
16
251
0.62
1.06
7.8
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
14
227
0.60
1.06
1.1
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
90
1.70
1.05
1.9
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
250
0.62
1.05
7.8
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
5
106
0.46
1.03
7.4
2.7
mmol/l
1.3
0.6
—
5
67
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
72
866
0.79
1.02
1.9
2.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
5
109
0.45
1.02
7.4
2.7
kpa
4.9
5.0
—
5
100
(3027944) Amphetamines [Presence] in Urine
16
248
0.63
1.02
7.8
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
158
0.56
1.01
1.3
1.5
—
—
—
0
0
(3000492) Spirometry study
23
329
0.68
1.01
1.3
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
35
2.02
1.00
1.0
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
84
1.69
0.99
1.2
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
23
2.19
0.98
1.0
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
23
2.19
0.98
1.0
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
41
313
1.35
0.97
1.5
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
31
0.00
0.97
0.0
2.3
—
4.9
—
0
25
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
48
603
0.76
0.96
1.8
2.0
mg/l
2.0
2.8
3.62
39
531
(3034770) Mitochondria Ab [Titer] in Serum
13
78
1.69
0.93
1.1
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
47
372
1.30
0.89
2.4
2.4
ng/l
511.1
232.2
0.24
11
174
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
20
136
1.50
0.88
1.5
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
43
1.88
0.88
1.9
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
101
877
1.21
0.87
4.9
4.7
mmol/l
1.2
1.2
0.81
94
816
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
178
0.61
0.85
1.1
2.0
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
6
114
0.52
0.84
2.0
1.4
nmol/l
0.5
0.4
—
6
93
(3001122) Ferritin [Mass/volume] in Serum or Plasma
147
1618
0.84
0.84
2.7
2.9
ug/l
79.5
68.9
0.32
137
1546
(1002224) Polysomnography panel
12
189
0.62
0.84
1.2
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
16
236
0.66
0.83
7.7
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
261
2733
0.82
0.83
3.6
4.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
102
891
1.20
0.82
1.7
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
58
1.75
0.80
1.2
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.5
—
1.3
—
0
18
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
38
479
0.77
0.79
9.4
4.1
mg/mmol
2.5
9.0
2.37
23
318
(3000330) Specific gravity of Urine by Test strip
13
82
1.61
0.79
5.0
2.0
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
3.0
—
26.7
—
0
26
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
27
0.00
0.77
0.0
1.0
—
1.1
—
0
10
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
24
2.10
0.75
1.0
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
84
1.57
0.73
1.8
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
37
462
0.78
0.72
8.7
3.3
mg/l
17.8
204.8
0.65
23
307
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
31
396
0.76
0.72
1.7
1.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
26
340
0.75
0.71
1.7
2.2
mmol/l
2.4
2.4
0.26
19
296
(44813793)
5
26
1.94
0.71
1.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
1.0
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
38
304
1.28
0.68
1.5
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
29
371
0.76
0.68
1.6
1.3
iu/l
29.9
24.3
0.44
29
320
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
49
1.65
0.62
1.4
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
50
1.61
0.61
1.4
3.6
—
457.3
—
0
6
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
30
1.68
0.61
1.0
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
30
1.68
0.61
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
15
105
1.45
0.61
2.5
1.4
—
—
—
0
0
(44790047)
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(44790048)
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(44806118)
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(44790049)
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
21
0.00
0.60
0.0
1.0
—
95.7
—
0
16
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
22
0.00
0.59
0.0
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
64
1.58
0.59
1.3
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
35
1.73
0.58
10.2
1.9
—
—
—
0
0
(4010399)
10
149
0.66
0.58
1.2
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
16
217
0.72
0.57
1.3
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
37
305
1.24
0.54
1.2
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
39
1.55
0.53
3.3
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
40
1.51
0.52
1.0
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
39
462
0.82
0.50
1.3
1.4
titre
336.0
472.4
—
5
89
(3022621) pH of Urine by Test strip
20
154
1.32
0.49
2.9
2.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
107
0.65
0.49
5.7
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
200
0.74
0.49
8.1
1.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
7
110
0.63
0.49
1.4
1.4
pmol/l
34.8
54.1
—
7
105
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
44
513
0.84
0.48
1.8
1.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
47
1.50
0.48
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
5
81
0.61
0.46
1.0
1.1
—
0.6
—
0
33
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
24
194
1.25
0.43
1.7
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
39
333
1.19
0.43
1.1
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
91
0.65
0.43
1.0
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
15
0.00
0.41
0.0
1.4
—
37.4
—
0
10
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.8
—
3.4
—
0
15
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
16
0.00
0.41
0.0
1.0
—
252.7
—
0
9
(21491868) Cryoglobulin [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
11
79
1.41
0.41
2.0
4.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
17
0.00
0.40
0.0
2.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.40
0.0
2.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
34
1.48
0.40
1.0
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
80
727
1.13
0.40
2.7
2.3
ng/l
10.0
21.0
1.53
28
264
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
0
18
0.00
0.40
0.0
2.2
—
0.9
—
0
13
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
19
0.00
0.39
0.0
1.2
—
1050.8
—
0
14
(3019309) Folate [Moles/volume] in Red Blood Cells
35
300
1.19
0.38
1.5
1.6
nmol/l
1089.3
1145.6
0.16
27
245
(40768804) Tissue Pathology biopsy report
127
1190
1.11
0.37
2.1
1.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
76
0.65
0.36
1.4
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
80
0.62
0.35
1.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
125
0.71
0.35
1.6
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
6
46
1.31
0.33
1.5
1.5
ug/l
78.8
164.6
—
6
41
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
11
84
1.32
0.30
1.0
1.2
—
2.1
—
0
9
(4034850)
12
93
1.30
0.30
11.1
7.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
55
1.28
0.30
1.0
1.3
—
1.2
—
0
7
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
49
441
1.13
0.30
1.5
1.5
pmol/l
485.1
37772811.5
0.80
42
413
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
51
563
0.89
0.29
1.2
1.3
iu/ml
9.3
22.5
2.88
11
175
(4035726)
13
162
0.79
0.29
1.0
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
11
85
1.30
0.28
1.0
1.2
—
15.9
—
0
19
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
25
215
1.18
0.27
5.7
4.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
22
257
0.85
0.27
3.8
2.3
%
27.6
24.6
0.39
17
218
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
280
2745
1.10
0.27
6.5
4.8
mu/l
1.6
2.1
0.61
264
2644
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
71
0.70
0.26
1.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
71
0.70
0.26
1.0
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
91
968
0.92
0.26
1.5
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
213
0.84
0.26
1.2
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
14
170
0.82
0.25
8.7
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
82
767
1.09
0.25
2.2
3.1
mmol/l
2.3
2.3
0.39
75
708
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
17
202
0.83
0.25
1.6
2.0
u/ml
15.1
36.0
1.16
17
192
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
70
650
1.10
0.25
1.6
1.7
mg/l
0.5
0.7
0.41
44
475
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
198
1.17
0.25
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
201
0.84
0.24
1.1
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
38
1.32
0.23
10.2
2.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
22
191
1.16
0.22
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
124
0.80
0.22
1.1
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
208
2025
1.07
0.22
2.7
3.4
mm/h
7.3
8.2
0.80
197
1919
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
5
42
1.19
0.21
1.2
1.6
—
13.5
—
0
5
(3004775) Volume in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
1.3
—
819.2
—
0
6
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
4.2
—
7.7
—
0
13
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
9.4
—
172.7
—
0
6
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
48
1.25
0.20
1.0
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
99
1.22
0.20
2.8
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
32
289
1.12
0.20
1.2
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
319
3159
1.11
0.18
12.2
8.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
77
812
0.93
0.18
2.1
1.9
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
19
166
1.15
0.18
2.3
2.1
nmol/l
12.7
13.5
0.17
19
156
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
5
66
0.75
0.17
1.8
1.3
u/ml
450.8
197.7
—
5
39
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
5
67
0.74
0.17
1.0
1.3
—
4.7
—
0
24
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
6
76
0.79
0.16
1.2
2.5
mg/l
6.2
9.0
—
6
69
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
22
197
1.12
0.15
3.1
2.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
12
140
0.85
0.15
17.4
7.5
mmol/l
7.0
7.1
0.01
12
135
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
30
327
0.91
0.15
1.6
1.3
iu/ml
85.9
149.5
1.18
14
148
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
82
1.10
0.15
2.6
8.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
87
834
1.06
0.15
1.5
1.7
pmol/l
100.8
96.0
0.31
43
477
(3048689) Calprotectin [Mass/mass] in Stool
42
447
0.93
0.13
1.5
2.5
ug/g
190.4
83.9
0.47
29
350
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
10
117
0.85
0.13
1.1
1.4
—
—
—
0
0
(3019225) pH of Specimen
17
190
0.89
0.13
3.8
3.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
109
0.82
0.13
1.2
2.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
114
1.15
0.12
1.2
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
14
157
0.89
0.11
1.4
1.2
u/l
10.8
10.6
0.02
14
129
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
10
115
0.87
0.11
1.2
1.5
g/l
1.1
1.2
—
10
109
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
58
605
0.95
0.10
1.8
1.8
—
—
—
0
0
(3012544) pH of Venous blood
15
135
1.12
0.10
2.0
3.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
46
1.09
0.09
1.0
1.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
5
61
0.82
0.08
1.0
1.0
—
0.6
—
0
16
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
66
1.06
0.08
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
72
0.83
0.07
1.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
73
0.82
0.07
1.7
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
82
0.85
0.07
1.0
2.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
83
0.84
0.07
2.0
2.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
86
1.05
0.07
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
87
1.04
0.07
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
88
1.02
0.07
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
91
0.88
0.07
1.4
1.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
8
90
0.89
0.07
3.4
7.8
%
2.2
1.5
—
8
90
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
8
90
0.89
0.07
3.4
7.9
%
0.9
0.7
—
8
90
(3014007) Fractional oxyhemoglobin in Arterial blood
8
92
0.87
0.07
3.4
7.7
%
95.3
94.3
—
8
92
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
9
104
0.86
0.06
1.3
1.2
ug/l
1.4
2.7
—
9
93
(3003740) Influenza virus B Ag [Presence] in Specimen
9
105
0.85
0.06
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
105
0.85
0.06
1.2
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
237
2386
0.98
0.04
5.9
4.3
pmol/l
14.9
14.2
4.75
221
2279
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
19
200
0.95
0.04
1.5
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
15
159
0.94
0.03
3.1
6.8
mmol/l
0.3
0.6
—
8
120
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
169
0.94
0.03
2.3
1.9
ml/min/173m2
85.8
87.5
—
9
69
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
81
798
1.02
0.03
1.3
1.3
u/ml
0.4
2.2
1.96
22
229
(3000991) Gas panel - Venous blood
12
128
0.94
0.02
2.9
6.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
127
0.94
0.01
1.8
1.7
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
10
98
1.02
0.00
1.8
1.6
%
96.5
95.0
—
10
92
(3036489) Thrombin time
12
119
1.01
0.00
1.9
1.6
s
19.8
20.7
0.58
12
101
(3003327) Ova and parasites identified in Stool by Light microscopy
13
131
0.99
0.00
1.8
1.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
15
155
0.97
0.00
12.7
9.8
inr
1.0
1.1
—
6
32
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
106
1.04
0.00
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
17
174
0.98
0.00
1.7
2.6
g/l
0.2
0.2
0.37
17
167
(3042936) Bacteria identified in Isolate by Culture
29
294
0.99
0.00
1.5
2.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
6
0.00
0.00
0.0
1.0
—
479.7
—
0
6
(3020393) Adenovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
15.8
—
0
6
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
2.6
—
0
6
(3035880) pH of Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
6
0.00
0.00
0.0
1.0
—
170.3
—
0
6
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.4
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
0.7
—
0
9
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
0.0
—
0
8
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
3.0
—
324.4
—
0
5
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
49
1.02
0.00
3.6
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.0
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
54
0.92
0.00
1.0
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3020891) Body temperature
5
56
0.89
0.00
2.2
4.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
15.3
—
0
8
(3044242) Glucose [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
10.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.1
—
35.3
—
0
7
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.7
—
7.1
—
0
9
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: MSMED_FINGOLIMOD – Use of fingolimod
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).